Cite
Bienias P, Kostera-Pruszczyk A, Miszczak-Knecht M, et al. Propafenone is not effective for severe ventricular arrhythmias in Andersen-Tawil syndrome. Arch Med Sci. 2016;14(1):248-250doi: 10.5114/aoms.2016.61010.
Bienias, P., Kostera-Pruszczyk, A., Miszczak-Knecht, M., Ciurzyński, M., & Pruszczyk, P. (2018). Propafenone is not effective for severe ventricular arrhythmias in Andersen-Tawil syndrome. Archives of medical science : AMS, 14(1), 248-250. https://doi.org/10.5114/aoms.2016.61010
Bienias, Piotr, et al. "Propafenone is not effective for severe ventricular arrhythmias in Andersen-Tawil syndrome." Archives of medical science : AMS vol. 14,1 (2018): 248-250. doi: https://doi.org/10.5114/aoms.2016.61010
Bienias P, Kostera-Pruszczyk A, Miszczak-Knecht M, Ciurzyński M, Pruszczyk P. Propafenone is not effective for severe ventricular arrhythmias in Andersen-Tawil syndrome. Arch Med Sci. 2018 Jan;14(1):248-250. doi: 10.5114/aoms.2016.61010. Epub 2016 Jun 30. PMID: 29379555; PMCID: PMC5778416.
Copy
Download .nbib